Our findings are similar to one recent study [19] in liver cancer, which revealed that hepatocellular carcinoma patients with portal vein thrombosis showed a statistical significant serum Lp(a) level higher than those without portal vein thrombosis. This evidence concerns the gene LPA and Portal vein thrombosis.